This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brik, R.
Right arrow Articles by Gershoni-Baruch, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brik, R.
Right arrow Articles by Gershoni-Baruch, R.
Related Collections
Right arrow Infectious Disease & Immunity
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 103 No. 5 May 1999, p. e70

ELECTRONIC ARTICLE:
Familial Mediterranean Fever: Clinical and Genetic Characterization in a Mixed Pediatric Population of Jewish and Arab Patients

Received Sep 7, 1998; accepted Nov 30, 1998.

Riva Brik*, Dagger , Marwan Shinawi*, Ilana Kepten§, Moshe Berant*, and Ruth Gershoni-Baruch§

From the * Department of Pediatrics, Dagger  Pediatric Rheumatology Services, and § Institute of Human Genetics, Rambam Medical Center and Technion-Israel Institute of Technology Faculty of Medicine, Haifa, Israel.

Objective.  Familial Mediterranean fever (FMF) is an autosomal recessive hereditary disease which primarily affects non-Ashkenazi Jews, Armenians, Arabs, and Turks. The gene responsible for the disease (MEFV/FMF) has been recently identified. Four common mutations in exon 10 of the MEFV gene seem to account for 86% of the DNA variations identified in patients with FMF. We conducted a phenotype/genotype correlation study in a mixed population of Jewish and Arab children with FMF.

Study Design.  Seventy patients clinically diagnosed as having FMF underwent molecular genetic studies using polymerase chain reaction and restriction endonuclease digestion methods to detect the presence of the four mutations (M694V, M680I, V726A, M694I). We then correlated the presence of each mutation with ethnic origin, age of onset, clinical manifestations, disease severity, and occurrence of amyloidosis.

Results.  The M694V mutation, which is predominant in non-Ashkenazi Jews, was found in 92% of our Jewish patients and in only 30% of the Arab patients. All four mutations were identified among 94% of the Arab patients, but with no particular prevalence for any one of them. The presence of a homozygous M694V mutation was significantly associated with a more severe form of the disease: the clinical onset of the disease manifested at an earlier age; the number of attacks per month was higher; the global assessment by the treating physician and the severity of pain scored higher; and arthritis was more frequent. Only patients with the M694V mutation had a family history of amyloidosis. No association was found between the type of mutation and the predominance of fever, abdominal pain, pleuritis, skin eruption, or response to colchicine in the clinical picture.

Conclusions.  Homozygosity for the M694V mutation, predominant among North African Jews, is associated with a severe course and prognosis for FMF. This mutation is less common among Arabs and, when present, occurs almost only in heterozygous form. In Arab patients, the disease tends to run a milder course and seems to bear a better prognosis. The phenotype/genotype patterns that are evident from our study of a mixed series of Jewish and Arab children with FMF might provide a rational basis for counseling about the natural history of the disease and for clinical treatment of FMF patients and their families.  Key words:  FMF, MEFV gene, mutations.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
B. Balci-Peynircioglu, A. L. Waite, P. Schaner, Z. E. Taskiran, N. Richards, D. Orhan, S. Gucer, S. Ozen, D. Gumucio, and E. Yilmaz
Expression of ASC in Renal Tissues of Familial Mediterranean Fever Patients with Amyloidosis: Postulating a Role for ASC in AA Type Amyloid Deposition
Experimental Biology and Medicine, November 1, 2008; 233(11): 1324 - 1333.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
I. Kone Paut, M. Dubuc, J. Sportouch, P. Minodier, J. M. Garnier, and I. Touitou
Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features
Rheumatology, November 1, 2000; 39(11): 1275 - 1279.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
F. Yalcinkaya, N. Cakar, M. Misirlioglu, N. Tumer, N. Akar, M. Tekin, H. Tastan, H. Kocak, N. Ozkaya, and A. H. Elhan
Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation-independent amyloidosis
Rheumatology, January 1, 2000; 39(1): 67 - 72.
[Abstract] [Full Text] [PDF]